RESEARCH CHEMICALS NETHERLANDS - AN OVERVIEW

Tirzepatide currently being a twin GLP-one and GIP agonist, it's instructed the GIP component of twin agonism may be to blame for the extra reward, given the opportunity advantage of GIP receptor agonism on peripheral insulin sensitization. For that reason, tirzepatide was more practical than dulaglutide in reducing fasting dietary TAG [six,7].50